Full Name
Ratnagopal Pavanni
 
 
Email
gmsratna@nus.edu.sg
 

Publications

Results 21-28 of 28 (Search time: 0.005 seconds).

Issue DateTitleAuthor(s)
212005Impaired transcriptional upregulation of Parkin promoter variant under oxidative stress and proteasomal inhibition: Clinical associationTan E.K. ; Puong K.Y.; Chan D.K.Y.; Yew K.; Fook-Chong S. ; Shen H.; Ng P.W.; Woo J.; Yuen Y. ; Pavanni R. ; Wong M.C. ; Puvan K. ; Zhao Y.
222004MDR1, the blood-brain barrier transporter, is associated with Parkinson's disease in ethnic ChineseLee C.G. ; Tang K.; Cheung Y.B. ; Wong L.P.; Tan C.; Shen H.; Zhao Y.; Pavanni R. ; Lee E.J. ; Wong M.C. ; Chong S.S. ; Tan E.K. 
232004Nurr1 mutational screen in Parkinson's diseaseTan E.-K. ; Chung H.; Chandran V.R.; Tan C.; Shen H.; Yew K.; Pavanni R. ; Puvan K.-A. ; Wong M.-C. ; Teoh M.-L.; Yih Y.; Zhao Y.
242006PINK1 mutations in sporadic early-onset Parkinson's DiseaseTan E.-K. ; Yew K.; Chua E.; Puvan K.; Shen H.; Lee E.; Puong K.-Y.; Zhao Y.; Pavanni R. ; Wong M.-C.; Jamora D.; de Silva D. ; Moe K.-T.; Woon F.-P.; Yuen Y.; Tan L. 
252003Piribedil and bromocriptine in Parkinson's disease: A single-blind crossover studyTan E.K. ; Ratnagopal P. ; Han S.Y.; Wong M.C. 
262005Prescribing pattern in Parkinson's disease: Are cost and efficacy overriding factors?Tan E.-K. ; Yeo A.P.; Tan V. ; Pavanni R. ; Wong M.C. 
272005The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patientsTan E.K. ; Shen H.; Tan L.C.S. ; Farrer M.; Yew K.; Chua E.; Jamora R.D.; Puvan K. ; Puong K.Y.; Zhao Y.; Pavanni R. ; Wong M.C. ; Yih Y.; Skipper L.; Liu J.-J. 
282008Zolpidem and its effects on hypoxic encephalopathyLo Y.L. ; Tan E.K. ; Ratnagopal P. ; Chan L.L. ; Tan T.E.